Artemetrx Specialty Drug Solutions, LLC is categorized under Business Analysis in Lexington, KY and active since 2012.
Artemetrx Specialty Drug Solutions, LLC was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Analysis business, which does work in the B2B market, and is classified as a Business Analysis, under code number by the NAICS.
If you are seeking more information, feel free to contact Brenda Motheral at the company’s single location by writing to 1648 McGrathiana Parkway # 380, Lexington, Kentucky KY 40511 or by phoning (859) 277-1447. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Artemetrx Specialty Drug Solutions, LLC |
| Contact Person: | Brenda Motheral |
| Address: | 1648 McGrathiana Parkway # 380, Lexington, Kentucky 40511 |
| Phone Number: | (859) 277-1447 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Analysis |
| Share This Business: |
Artemetrx Specialty Drug Solutions, LLC was started in 2012 to provide professional Business Analysis under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Brenda Motheral for inquiries that concern Artemetrx Specialty Drug Solutions, LLC by calling the company number (859) 277-1447, as your correspondence is most welcome. Additionally, the physical location of the single location of Artemetrx Specialty Drug Solutions, LLC can be found at the coordinates 38.0971338,-84.4908423 as well as the street address 1648 McGrathiana Parkway # 380 in Lexington, Kentucky 40511.
For its online presence, you may visit Artemetrx Specialty Drug Solutions, LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.